Cerebral mucormycosis: intranasal route to deliver amphotericin B for effective management?

Abstract

As cerebral mucormycosis is devastating in nature, here we discuss possible use of the intranasal route, in comparison to or in addition to intravenous administration, as a therapeutic approach to manage cases of mucormycosis with central nervous system involvement.